Prof. Francis Impens
Francis Impens is group leader at the VIB-UGent Center for Medical Biotechnology and full professor at the Department for Biomolecular Medicine, Ghent University. He investigates host-bacteria interactions using innovative mass spectrometry-based approaches with the aim to develop novel antimicrobial therapies and vaccines.
Prof. Jan Gettemans
Jan Gettemans is full professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is research on nanobodies (single domain antibodies) and their implementation in a diverse array of (bio)medical settings.
Prof. Bruno De Geest
Our lab leverages the power of chemistry, biotechnology and nanotechnology to engineer the immune system at better responding to internal threats such as cancer and external threats such as viral pathogens and lethal drug substances. In this context we aim to intervene at different levels in the process of innate immune activation, antigen presentation and the generation of adaptive immunity to clear or protect the host from a specific threat.
Prof. Hendrik Feys
Hendrik Feys is a Principal Investigator at the Belgian Red Cross Flanders Transfusion Research Center. The center has a research focus on blood derived products and their applicability in regenerative medicine. Hendrik is a visiting professor at the Department of Diagnostics Sciences at Ghent University.
Prof. Stefaan De Smedt
Director of the Lab of General Biochemistry & Physical Pharmacy at UGent. Served as dean of his Faculty and member of Board of Directors of UGent. Has been a Guest Professor at various universities in Belgium and China and is Deputy Editor-in-Chief of the Journal of Controlled Release. His research is at the interface between drug delivery, biophysics and material sciences.
Prof. Andre Skirtach
Prof. Frank Speleman
Frank Speleman is professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is the study of perturbed gene regulatory processes in paediatric cancer, more specifically neuroblastoma and T-ALL.
Prof. Nico Callewaert
Nico Callewaert is group leader and director of the VIB-UGent Center for Medical Biotechnology and full professor in biochemistry and biotechnology at Ghent University. His research interests focus on the invention of technologies for medicine, proteins and sugars.
Prof. Kevin Braeckmans
Kevin Braeckmans is Full Professor at Ghent University, faculty of Pharmaceutical Sciences. He is co-director of the Lab. Of General Biochemistry and Physical Pharmacy and group leader of the Biophotonics Research Group. His focus is on light-based technologies for investigating and facilitating drug delivery to cells and tissues, including for cell therapy applications.
Prof. Stan Monstrey
Former Chairman of the Department of Plastic Surgery and Burn Center at the Ghent University Hospital.
Prof. Jolanda van Hengel
Prof. Jolanda van Hengel is heading the medical cell biology group. Her group focuses on the in vitro engineering of functional myocardium that mimics human heart tissue for analysis of myocardial function. Also her group tries to obtain a suitable stem cell type for in vitro meat production.TISSUE ENGINEERING RESEARCH, CELL THERAPY, GENE THERAPY, ORGANOIDS AND ORGANONCHIP, MICROFLUIDICS AND LABONCHIP, CELLS, 3D CULTURES AND ORGANOIDS, BIOMATERIALS AND PROCESSING, ANALYTIC TOOLS IN GENE, CELL AND TISSUE ENGINEERING, GENES & NANODELIVERY SYSTEMS, REGULATORY AND CLINICAL TRIALS, GMP MANUFACTURING
Prof. Kristl Vonck
Kristl Vonck is Head of the Department ‘Head and Skin’ at Ghent University and full professor of neurology at the department of Neurology at Ghent University Hospital. Research interests include epilepsy, neuromodulation, bioelectronic medicine and neurophysiological home-monitoring of neurological disorders and is performed at the 4brain lab.